Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors

被引:131
|
作者
Vanderheyden, PML
Fierens, FLP
De Backer, JP
Fraeyman, N
Vauquelin, G
机构
[1] Free Univ Brussels, Dept Prot Chem, B-1640 Rhode St Genese, Belgium
[2] Heymans Inst Pharmacol, B-9000 Ghent, Belgium
关键词
angiotensin II; AT(1) receptors; CHO cells; calcium transients; extracellular acidification; inositol trisphosphate; antagonist; candesartan; surmountable; insurmountable;
D O I
10.1038/sj.bjp.0702398
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 CHO-K1 cells that were stably transfected with the gene for the human AT(1) receptor (CHO-AT(1) cells) were used for pharmacological studies of non-peptide AT(1) receptor antagonists. 2 In the presence of 10 mM LiCl, angiotensin II caused a concentration-dependent and long-lasting increase of inositol phosphates accumulation with an EC50 of 3.4 nM. No angiotensin II responses are seen in wild-type CHO-K1 cells. 3 [H-3]-Angiotensin II bound to cell surface AT(1) receptors (dissociates under mild acidic conditions) and is subject to rapid internalization 4 Non-peptide selective AT(1) antagonists inhibited the angiotensin II (0.1 mu M) induced IP accumulation and the binding of [H-3]-angiotensin II (1 nM) with the potency order: candesartan > EXP3174 > irbesartan > losartan. Their potencies are lower in the presence of bovine serum albumin. 5 Preincubation with the insurmountable antagonist candesartan decreased the maximal angiotensin II induced inositol phosphate accumulation up to 94% and, concomitantly, decreased the maximal binding capacity of the cell surface receptors. These inhibitory effects were half-maximal for 0.6 nM candesartan and were attenuated by simultaneous preincubation with 1 mu M losartan indicating a syntopic action of both antagonists. 6 Losartan caused a parallel rightward shift of the angiotensin II concentration-response curves and did not affect the maximal binding capacity. EXP3174 (the active metabolite of losartan) and irbesartan showed a mixed-type behavior in both functional and binding studies. 7 Reversal of the inhibitory effect was slower for candesartan as compared with EXP3174 and irbesartan and it was almost instantaneous for losartan, suggesting that the insurmountable nature of selective AT(1) receptor antagonists in functional studies was related to their long-lasting inhibition.
引用
收藏
页码:1057 / 1065
页数:9
相关论文
共 50 条
  • [1] Insurmountable AT1 angiotensin receptor antagonists dissociate slowly from the vascular AT1 receptor.
    Murphy, TJ
    FASEB JOURNAL, 1998, 12 (05): : A1002 - A1002
  • [2] Antagonists of the AT1 receptor for angiotensin II
    Kawecka-Jaszcz, Kalina
    Czarnecka, Danuta
    Wojciechowska, Wiktoria
    ARTERIAL HYPERTENSION, 2006, 10 : A1 - A15
  • [3] Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells
    Le, MT
    De Backer, JP
    Hunyady, L
    Vanderheyden, PML
    Vauquelin, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 513 (1-2) : 35 - 45
  • [4] Insurmountable angiotensin AT1 receptor antagonists:: the role of tight antagonist binding
    Fierens, FLP
    Vanderheyden, PML
    De Backer, JP
    Vauquelin, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (02) : 199 - 206
  • [5] Inhibition of Angiotensin II-Induced Inositol Phosphate Production by Triacid Nonpeptide Antagonists in CHO Cells Expressing Human AT1 Receptors
    Patrick M. L. Vanderheyden
    Ilse Verheijen
    Frederik L. P. Fierens
    Jean-Paul DeBacker
    Georges Vauquelin
    Pharmaceutical Research, 2000, 17 : 1482 - 1488
  • [6] Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors
    Vanderheyden, PML
    Verheijen, I
    Fierens, FLP
    DeBacker, JP
    Vauquelin, G
    PHARMACEUTICAL RESEARCH, 2000, 17 (12) : 1482 - 1488
  • [7] Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists-A perspective
    Naik, Prashant
    Murumkar, Prashant
    Giridhar, Rajani
    Yadav, Mange Ram
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (24) : 8418 - 8456
  • [8] POTENT AT1 SELECTIVE ANGIOTENSIN-II ANTAGONISTS
    DHANOA, DS
    BAGLEY, SW
    CHANG, RSL
    LOTTI, VJ
    SIEGL, PKS
    PATCHETT, AA
    GREENLEE, WJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 34 - MEDI
  • [9] Angiotensin II AT1 receptor antagonists and platelet activation
    López-Farré, A
    de Miguel, LS
    Montón, M
    Jiménez, A
    Lopez-Bloya, A
    Gómez, J
    Núñez, A
    Rico, L
    Casado, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 45 - 49
  • [10] Effects of angiotensin II and antagonists on AT1 receptor expression in mesangial cells
    Chansel, D
    Vandermeersch, S
    Llorens-Cortes, C
    Ardaillou, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 384 (2-3) : 223 - 230